SPC Hydrotalcite
Hydrotalcite 0.5g
OTC medication
SPC Co., Ltd.
MFDS item code 200704998 · Notified 2007.04.30
Antacid effect related to gastric and duodenal ulcers and excessive gastric acid
This medication exhibits antacid effects in gastrointestinal disorders such as gastric and duodenal ulcers, excessive gastric acid, and acute and chronic gastritis. It neutralizes stomach acid, protects the gastric mucosa, and alleviates symptoms. This helps improve upper abdominal pain or digestive disorders, aids in the healing of ulcers, and helps maintain a healthy digestive environment. Thanks to these effects, it is used to relieve discomfort in the stomach and treat gastrointestinal diseases.
Children aged 15 years and older and adults: As hydrotalcite, administer 0.5-1.0g orally 4 times a day between meals and at bedtime. Adjust according to age and symptoms.
Children aged 15 years and older: As hydrotalcite, administer 0.5-1.0g orally 4 times a day between meals and at bedtime. Adjust according to age and symptoms.
This medication should not be used in patients undergoing dialysis treatment. Long-term use may lead to accumulation of aluminum in the brain or bones, causing problems. Also, it should not be administered to children under 15 years of age. Care should be taken when administering to patients with low phosphate levels, those with weak heart function, frequent diarrhea, elevated magnesium levels, and poor kidney function. Particularly, patients with compromised kidney function are at risk for abnormalities in the brain or bones due to aluminum accumulation with prolonged use, so it is important to regularly check blood levels of aluminum, phosphate, calcium, and alkaline phosphatase. Long-term or high-dose use of this medication can lead to elevated blood magnesium levels or decreased phosphate levels, so the condition should be closely monitored. If any unusual symptoms appear, appropriate measures such as reducing the dosage or temporarily discontinuing the medication should be taken. Additionally, gastrointestinal side effects such as loss of appetite, dry mouth, diarrhea, and constipation may occasionally occur, so these symptoms should be reported. This medication may interfere with the absorption of tetracycline antibiotics, so it is advisable not to take them together. It can also alter the acidity (pH) of the intestinal environment or affect the absorption and excretion of other medications, so caution should be exercised with concurrently administered medications. Taking this medication in combination with milk or calcium supplements can lead to milk-alkali syndrome such as hypercalcemia or alkalosis, so symptoms should be carefully monitored, and if abnormalities occur, the dose should be discontinued.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that is well-ventilated, preferably at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the effectiveness of the medication and prevents deterioration.
White to light yellowish powder with a peculiar odor
200g/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.